Medical progress: Brucellosis

被引：985

作者：

Pappas, G ^{[1
]}

Akritidis, N ^{[1
]}

Bosilkovski, M ^{[1
]}

Tsianos, E ^{[1
]}

机构：

[1] Univ Hosp Ioannina, Dept Internal Med, Brucellosis Unit, Ioannina 45110, Greece

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 22期

关键词：

D O I：

10.1056/NEJMra050570

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2325 / 2336

页数：12

共 99 条

[41] AN EVALUATION OF DIAGNOSTIC METHODS FOR BRUCELLOSIS - THE VALUE OF BONE-MARROW CULTURE [J].

GOTUZZO, E ;

CARRILLO, C ;

GUERRA, J ;

LLOSA, L .

JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (01) :122-125

[42] In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells [J].

Gross, A ;

Terraza, A ;

Ouahrani-Bettache, S ;

Liautard, JP ;

Dornand, J .

INFECTION AND IMMUNITY, 2000, 68 (01) :342-351

[43] The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae [J].

Guzmán-Verri, C ;

Manterola, L ;

Sola-Landa, A ;

Parra, A ;

Cloeckaert, A ;

Garin, J ;

Gorvel, JP ;

Moriyón, I ;

Moreno, E ;

López-Goñi, I .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12375-12380

[44] TOLERANCE OF THE HUMAN BRUCELLOSIS VACCINE AND THE INTRADERMAL REACTION TEST FOR BRUCELLOSIS [J].

HADJICHRISTODOULOU, C ;

VOULGARIS, P ;

TOULIERES, L ;

BABALIS, T ;

MANETAS, S ;

GOUTZIANA, G ;

KASTRITIS, I ;

TSELENTIS, I .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (02) :129-134

[45] Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages [J].

Jubier-Maurin, V ;

Boigegrain, RA ;

Cloeckaert, A ;

Gross, A ;

Alvarez-Martinez, MT ;

Terraza, A ;

Liautard, J ;

Köhler, S ;

Rouot, B ;

Dornand, J ;

Liautard, JP .

INFECTION AND IMMUNITY, 2001, 69 (08) :4823-4830

[46] Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179] [J].

Karabay, O ;

Sencan, I ;

Kayas, D ;

Sahin, I .

BMC INFECTIOUS DISEASES, 2004, 4 (1)

[47] The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable? [J].

Kaufmann, AF ;

Meltzer, MI ;

Schmid, GP .

EMERGING INFECTIOUS DISEASES, 1997, 3 (02) :83-94

[48] Brucellosis in pregnant women [J].

Khan, MY ;

Mah, MW ;

Memish, ZA .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) :1172-1177

[49] Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis [J].

Ko, J ;

Gendron-Fitzpatrick, A ;

Splitter, GA .

JOURNAL OF IMMUNOLOGY, 2002, 168 (05) :2433-2440

[50] Molecular host-pathogen interaction in brucellosis: Current understanding and future approaches to vaccine development for mice and humans [J].

Ko, JY ;

Splitter, GA .

CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :65-+

← 1 2 3 4 5 6 7 8 9 10 →